Drug · DIN 02237735
RAXAR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 27, 1999; first marketed July 1, 1998.
- Drug Identification Number (DIN)
- 02237735
- Company (DIN owner)
- Otsuka Pharma GmbhFrankfurt Am Main, Germany
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Grepafloxacin J01MA11
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GREPAFLOXACIN (GREPAFLOXACIN HYDROCHLORIDE) | 200 MG | TAB |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 9, 1998: NOC 2939New Drug Submission (NDS)